Cases Studies from Winther
April 16, 2021
The next frontier in precision oncology sits at the intersection of transcriptomics (RNA sequencing), AI technology, and the multiple global validated data sources of existing therapies and clinical trials. As evidenced in the WINTHER trial (Nature Med, April 2019), RNA analysis surfaces actionable data and gives patients and their oncologists the tools to make better treatment decisions about advanced cancers whose biomarkers are hiding in plain sight. This article presents six cases studies from the WINTHER clinical trial to illustrate the power of this new approach to treatment decision-making.